KINISOQUIN

Quercis Pharma AG

Application Filed: 2020-03-16
Trademark Application Details
Trademark Logo KINISOQUIN

Mark For: KINISOQUIN™ trademark registration is intended to cover the categories of pharmaceutical preparations including those for the treatment of thrombosis, sickle cell disease, chronic obstructive pulmonary disease, amyotrophic lateral sclerosis, pancreatic cancer, ovarian cancer, ebola virus and covid-19. [all]

Status

2020-12-14 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88836223
Mark Literal ElementsKINISOQUIN
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationTMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED 2020-07-30
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameVictoria D Summerfield

Timeline

2020-03-16Application Filed
2020-03-19Location: NEW APPLICATION PROCESSING
2020-03-19Status: Live/Pending
2020-03-19Transaction Date
2020-07-30Location: TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED
2020-07-30Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi

Trademark Parties (Applicants & Owners)

Party: Quercis Pharma AG
AddressNordstrasse 5 Zug SWITZERLAND 6300
Legal Entity TypeCorporation
Legal Entity StateSWITZERLAND

Attorney of Record

VICTORIA D SUMMERFIELD
PEPPER HAMILTON LLP
501 GRANT STREET SUITE 300
PITTSBURGH, PA 15219

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: PHARMACEUTICAL PREPARATIONS INCLUDING THOSE FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRON
IC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPH
IC LATERAL SCLEROSIS, PANCREAT
IC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051PHARMACEUTICAL PREPARATIONS INCLUDING THOSE FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19

Trademark Filing History

DescriptionDateProceeding Number
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-07-306325
NON-FINAL ACTION WRITTEN2020-07-3085327
NON-FINAL ACTION E-MAILED2020-07-306325
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-07-17
NON-FINAL ACTION WRITTEN2020-07-1785327
NON-FINAL ACTION E-MAILED2020-07-17
ASSIGNED TO EXAMINER2020-07-1585327
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-03-20
NEW APPLICATION ENTERED IN TRAM2020-03-19

© 2021 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed